Rare diseases
Showing of 18 results
Harrington Discovery Institute Announces 2026 Scholar-Innovator Award Recipients
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.
Dee and Jimmy Haslam Make $12.5 Million Transformational Investment in Blood Cancer Research and Treatments at University Hospitals
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center.
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases.
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation.
Harrington Discovery Institute Announces 2025 Scholar-Innovator Award Recipients
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation.
Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre
Renowned US Neuroscientist and Harvard Professor brings extensive expertise in academia and industry to advance rare disease research.
Synergy for Change Award to Morgan Stanley GIFT and Harrington Discovery Institute
Award highlights collaboration between for profit and non-profit achieving great impact.